Sandoz set to go it alone

By Megan Brodie 2 years ago | In Companies
  • 2 years ago
Novartis CEO announces Sandoz spin-off. Image: LinkedIn

26 August 2022 Novartis will spin off its generics and biosimilars division into a stand-alone…

This is subscriber-only content. Please login to continue reading.